DebasishBanerjee St George's University Hospital NHS Foundation TrUnited Kingdom

Professor Debasish Banerjee is a nephrologist with special interest in cardiovascular complications of chronic kidney disease. He keen on service development and education on heart diseases in CKD particularly heart failure. He established the multidisciplinary CKD-heart failure clinic in St George’s Hospital. His research is on vascular and cardiac changes in CKD, the risk factors and intervention with randomised controlled trials. He is co-Director of the Translational and Clinical Sciences Research Institute at St George’s University of London. He works on various roles for the International Society of Nephrology, European Society of Cardiology and UK Kidney association. He is keen on teaching of undergraduate medical students; currently the Quality lead for MBBS program and joint Head of the Section of Clinical Teachers in St Georges’ University of London.

Day 1 - Sunday April 14, 2024

Time	Session

09:00 am 10:30 am	Innovations in Transplantation Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deUniversity hospital ErlangenGermany Update in Robotic Kidney Transplantation RajeshSivaprakasam Speaker rajesh.sivaprakasam@nhs.netUnited Kingdom Progress in Xenotransplantation MeganSykes Speaker ms3976@cumc.columbia.eduUnited States Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation CarolineLamarche Speaker caroline.lamarche.1@umontreal.caUniversité de MontréalCanada Post Transplant TMA-pathogenesis and Management LilianMonteiro P. Palma Speaker lilian.palma@icloud.comState University of CampinasBrazil Q and A Hall A
10:30 am 11:00 am	Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy JonathanBarratt Spotlight Speaker jb81@leicester.ac.ukUniversity of Leicester, Leicester, UKUnited Kingdom Spotlight Stage 1 (exhibition hall)
11:00 am 12:00 pm	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) AgnesFogo Chairperson agnes.fogo@vanderbilt.eduUnited States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria Hall A
12:15 pm 01:15 pm	Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session Domingo Casadei Chairperson drdomingocasadei@gmail.com VivekanandJha Chairperson vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia How to Achieve Transparent and Regulated Organ Donation and Transplantation Maria AmaliaMatamoros Speaker amatamoros@cehcr.comCosta Rica Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism LilianaBisigniano Speaker lbisigniano@incucai.gov.arLiliana Bisigniano MDArgentina How to Handle Cases of Presumed Transplant Tourism KenSakai Speaker kensakai@med.toho-u.ac.jpDepartment of Nephrology, Toho University Omori Medical CenterJapan Q and A Hall C1
02:45 pm 03:30 pm	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) ErangaWijewickrama Spotlight Chairperson erangasw@clinmed.cmb.ac.lkFaculty of Medicine, University of ColomboSri Lanka Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala Magdalena Madero Spotlight Speaker madero.magdalena@gmail.comChief of Nephrology, Instituto Nacional de CardiolMexico VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
03:00 pm 04:00 pm	Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States FelipeInserra Chairperson felipe.inserra@gmail.comArgentina New Insights into the Mechanisms of Kidney Injury in the CRS WendyMcCallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States Novel Pharmacological Treatments of the CRS MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States Device-related Treatment for CRS ClaudioRonco Speaker cronco@goldnet.itInternational Renal Research Institute of VicenzaItaly Q and A Hall D
04:00 pm 04:30 pm	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis BradRovin Spotlight Speaker rovin.1@osu.eduThe Ohio State UniversityUnited States UptalPatel Spotlight Speaker uptal@hibio.comUnited States Spotlight Stage 1 (exhibition hall)
04:30 pm 05:30 pm	New Developments in CKD Epidemiology Research RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgArbor Research Collaborative for HealthUnited States MaartenTaal Chairperson maarten.taal1@nhs.netUniversity of NottinghamUnited Kingdom Big Data Lab Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker alevin@providencehealth.bc.caCanada Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukLondon School of Hygiene & Tropical MedicineUnited Kingdom Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

12:15 pm 01:15 pm	The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgArbor Research Collaborative for HealthUnited States Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease MARISOLTORRES TOLEDANO Speaker torres.t.marisol@gmail.comIMSS, MEXICO Mexico Co-management of Patients With Cardio-Kidney Diseases: Let’s End the Card-Neph War DebasishBanerjee Speaker dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom Co-management of Patients With Cardio-Kidney Diseases: Let’s End the Card-Neph War CharlesHerzog Speaker Charles.Herzog@cdrg.orgISN and Hennepin Healthcare/University of MinnesUnited States Q and A Hall C1

Time

Session

12:15 pm

01:15 pm

The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management

RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgArbor Research Collaborative for HealthUnited States

Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease

MARISOLTORRES TOLEDANO Speaker torres.t.marisol@gmail.comIMSS, MEXICO Mexico
Co-management of Patients With Cardio-Kidney Diseases: Let’s End the Card-Neph War

DebasishBanerjee Speaker dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom
Co-management of Patients With Cardio-Kidney Diseases: Let’s End the Card-Neph War

CharlesHerzog Speaker Charles.Herzog@cdrg.orgISN and Hennepin Healthcare/University of MinnesUnited States
Q and A

Hall C1

Day 3 - Tuesday April 16, 2024

Time	Session

09:00 am 10:00 am	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment DebasishBanerjee Chairperson dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom MegJardine Chairperson meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Setting the Scene MegJardine Speaker meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker d.wheeler@ucl.ac.ukUniversity College LondonUnited Kingdom Q and A Hall C4

Time

Session

09:00 am

10:00 am

Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment

DebasishBanerjee Chairperson dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom

MegJardine Chairperson meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia

Setting the Scene

MegJardine Speaker meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
DM and CKD: Which Treatment Should I Use for Different Populations?

KatherineTuttle Speaker Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States
How to Design Studies on Answering Unanswered Questions

VladoPerkovic Speaker vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes

DavidWheeler Speaker d.wheeler@ucl.ac.ukUniversity College LondonUnited Kingdom
Q and A

Hall C4